Please login to the form below

Not currently logged in
Email:
Password:

Breo Ellipta

This page shows the latest Breo Ellipta news and features for those working in and with pharma, biotech and healthcare.

Advair generics and acquisitions to hit GSK in 2019

Advair generics and acquisitions to hit GSK in 2019

Combined sales of all Ellipta products rose 29% to £2.04bn ($2.64bn). ... However the tough US market took a bite out of Breo Ellipta, which saw sales decline (3% AER, 1% CER) because of pricing pressure, despite strong volume growth.

Latest news

  • Sovaldi pushes Gilead to the top of US pharma list Sovaldi pushes Gilead to the top of US pharma list

    The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of

  • China weighs heavy on GSK figures in Q3 China weighs heavy on GSK figures in Q3

    There were also launches for melanoma drugs Tafinlar (dabrafenib) and Mekinist (trametinib), Tivicay (dolutegravir) for HIV via GSK's ViiV joint venture with Pfizer and Shionogi, and new COPD therapy Breo ... Ellipta (fluticasone furoate and vilanterol).

  • GSK wins US approval for Seretide successor Breo Ellipta GSK wins US approval for Seretide successor Breo Ellipta

    Breo Ellipta will help patients breathe better day-to-day and reduce the risk of future exacerbations, with a once-daily inhalation.”. ... The partners plan to launch Breo Ellipta in the US during the third quarter of this year.

  • GSK buoyed by FDA panel backing for Advair successor GSK buoyed by FDA panel backing for Advair successor

    Breo, delivered once-daily using a new Ellipta inhaler, is seen as a critical drug for GSK as it tries to defend its asthma and COPD franchise dominated by twice-daily ... Breo Ellipta (which will be sold as Relvar in Europe) is being positioned by GSK

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics